Related Experiment Videos
Adipose tissue as a source of hormones
The American Journal of Clinical Nutrition
|January 1, 1987
Summary
Obesity elevates reproductive cancer risk in women by increasing estrogenic stimulus. This is due to enhanced androgen conversion, increased adipose tissue conversion of androstenedione (A) to estrone (E1), and lower sex hormone-binding globulin (SHBG) levels.
Area of Science:
- Endocrinology
- Reproductive Health
- Oncology
Background:
- Obesity is a known risk factor for female reproductive cancers.
- The underlying mechanism involves increased estrogenic stimulation of target tissues.
- Estrogen metabolism and transport are significantly altered in obese individuals.
Purpose of the Study:
- To elucidate the mechanisms linking obesity to increased reproductive cancer risk in women.
- To explain the role of altered steroid hormone levels in this association.
Main Methods:
- Review of existing literature on obesity, estrogen metabolism, and cancer risk.
- Analysis of factors influencing androgen precursor availability and conversion to estrogen.
- Examination of the impact of obesity on sex hormone-binding globulin (SHBG) levels and estradiol (E2) availability.
Main Results:
- Obesity increases estrogenic stimulus via enhanced adrenal activity, increased conversion of androstenedione (A) to estrone (E1) in adipose tissue, and reduced SHBG levels leading to higher circulating estradiol (E2).
- Estrogen and steroid hormone levels in breast fluids are higher than in serum, potentially due to local synthesis or uptake.
- No significant differences in breast fluid estrogen levels were observed between normal women and those with breast disease.
Conclusions:
- Obesity-related hormonal changes, particularly elevated estrogenic activity, contribute to increased reproductive cancer risk.
- Further research into estrogen antagonists, such as progesterone, may explain the lack of difference in breast fluid estrogen levels.
- Understanding these mechanisms is crucial for developing targeted prevention and treatment strategies for obesity-associated cancers.